U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C58H80N10O17
Molecular Weight 1189.3126
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ASUDEMOTIDE

SMILES

CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CC3=CC=C(O)C=C3)NC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(O)=O

InChI

InChIKey=FIURBSUJWCYXNV-OXOWVKQUSA-N
InChI=1S/C58H80N10O17/c1-7-32(6)49(58(84)85)68-56(82)44(29-45(60)71)66-57(83)48(31(4)5)67-55(81)43(26-33-11-9-8-10-12-33)65-52(78)40(25-30(2)3)63-51(77)39(22-24-47(74)75)61-53(79)42(28-35-15-19-37(70)20-16-35)64-54(80)41(27-34-13-17-36(69)18-14-34)62-50(76)38(59)21-23-46(72)73/h8-20,30-32,38-44,48-49,69-70H,7,21-29,59H2,1-6H3,(H2,60,71)(H,61,79)(H,62,76)(H,63,77)(H,64,80)(H,65,78)(H,66,83)(H,67,81)(H,68,82)(H,72,73)(H,74,75)(H,84,85)/t32-,38-,39-,40-,41-,42-,43-,44-,48-,49-/m0/s1

HIDE SMILES / InChI

Molecular Formula C58H80N10O17
Molecular Weight 1189.3126
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 1
Optical Activity UNSPECIFIED

Asudemotide, also known as S-588410, an immunostimulant that was studied as adjuvant therapy in phase III clinical trials for patients with esophageal cancer. In addition, this drug participated in phase II clinical trials after first-line chemotherapy in patients with advanced and/or metastatic bladder cancer.

Approval Year

PubMed

PubMed

TitleDatePubMed
Immunotherapy for esophageal squamous cell carcinoma: a review.
2018 Aug 29

Sample Use Guides

S-588410 (Asudemotide) will be injected subcutaneously once weekly for 12 weeks and once every 2 weeks thereafter for 94 weeks.
Route of Administration: Other
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:09:33 GMT 2023
Edited
by admin
on Sat Dec 16 08:09:33 GMT 2023
Record UNII
30Q33TZ6A7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ASUDEMOTIDE
INN  
INN  
Official Name English
L-ISOLEUCINE, L-.ALPHA.-GLUTAMYL-L-TYROSYL-L-TYROSYL-L-.ALPHA.-GLUTAMYL-L-LEUCYL-L-PHENYLALANYL-L-VALYL-L-ASPARAGINYL-
Systematic Name English
HUMAN DEP DOMAIN-CONTAINING PROTEIN 1A-(294-302)-PEPTIDE
Common Name English
asudemotide [INN]
Common Name English
GLU-TYR-TYR-GLU-LEU-PHE-VAL-ASN-ILE
Systematic Name English
Code System Code Type Description
INN
9593
Created by admin on Sat Dec 16 08:09:33 GMT 2023 , Edited by admin on Sat Dec 16 08:09:33 GMT 2023
PRIMARY
NCI_THESAURUS
C166617
Created by admin on Sat Dec 16 08:09:33 GMT 2023 , Edited by admin on Sat Dec 16 08:09:33 GMT 2023
PRIMARY
PUBCHEM
75124286
Created by admin on Sat Dec 16 08:09:33 GMT 2023 , Edited by admin on Sat Dec 16 08:09:33 GMT 2023
PRIMARY
FDA UNII
30Q33TZ6A7
Created by admin on Sat Dec 16 08:09:33 GMT 2023 , Edited by admin on Sat Dec 16 08:09:33 GMT 2023
PRIMARY
CAS
1018833-53-8
Created by admin on Sat Dec 16 08:09:33 GMT 2023 , Edited by admin on Sat Dec 16 08:09:33 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY